.png)
Orionis Biosciences, a privately held company, announced a second multi-year collaboration with Genentech, a member of the Roche Group (OTCQX:RHHBY).
The goal of this partnership is to discover small-molecule monovalent glue medicines for novel and challenging targets in oncology.
Under
English (US) ·